Fundraising FoxAdjuvant Capital — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Curevo Vaccinecurevovaccine.cominMar 2025 · $110MAcquired
Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases.
BiotechHealthtechBothell, US
George Simeon(CEO)inGregory S. Curhan(CFO)Guy De La Rosa(CMO)in
Co-investorsHBM Healthcare InvestmentsMedicxiOrbiMedRA CapitalSanofi VenturesJanus Henderson Investors
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.